Morbillivirus experimental animal models: Measles virus pathogenesis insights from canine distemper virus

Viruses

Volumn 8, Issue 10, 2016, Pages

  da Fontoura Budaszewski, Renata ^a,b   von Messling, Veronika ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Animal models; Canine distemper virus; Morbillivirus genus; Pathogenesis

Indexed keywords

CD150 ANTIGEN; DNA VACCINE; MEASLES VACCINE; RIBONUCLEOPROTEIN; VIRUS GLYCOPROTEIN;

ANTIGEN RECOGNITION; CANINE DISTEMPER VIRUS; CANINE DISTEMPER VIRUS INFECTION; DISEASE SEVERITY; DOG; FERRET; GENETIC STABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; MEASLES; MEASLES VIRUS; MORBILLIVIRUS; MORBILLIVIRUS INFECTION; NEUROLOGICAL COMPLICATION; NONHUMAN; PATHOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); REVIEW; TAXONOMY; TROPISM; VIRAL CLEARANCE; VIRUS ATTENUATION; VIRUS TRANSMISSION; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; IMMUNE EVASION; IMMUNOLOGICAL TOLERANCE; MUSTELA PUTORIUS FURO; PATHOGENICITY; PHYSIOLOGY; VIRAL TROPISM;

ANIMALS; DISEASE MODELS, ANIMAL; DISTEMPER VIRUS, CANINE; DOGS; FERRETS; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; MEASLES VIRUS; VIRAL TROPISM;

EID: 84991574425     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8100274     Document Type: Review

References (95)

1. Rota, P.A.; Moss, W.J.; Takeda, M.; de Swart, R.L.; Thompson, K.M.; Goodson, J.L. Measles. Nat. Rev. Dis. Primers 2016, 2, 16049. [CrossRef] [PubMed]
2. Horzinek, M.C. Rinderpest: The second viral disease eradicated. Vet. Microbiol. 2011, 149, 295-297. [CrossRef] [PubMed]
3. Cutts, F.T.; Lessler, J.; Metcalf, C.J. Measles elimination: Progress, challenges and implications for rubella control. Expert Rev. Vaccines 2013, 12, 917-932. [CrossRef] [PubMed]
4. Zhao, J.; Shi, N.; Sun, Y.; Martella, V.; Nikolin, V.; Zhu, C.; Zhang, H.; Hu, B.; Bai, X.; Yan, X. Pathogenesis of canine distemper virus in experimentally infected raccoon dogs, foxes, and minks. Antiviral Res. 2015, 122, 1-11. [CrossRef] [PubMed]
5. Martinez-Gutierrez, M.; Ruiz-Saenz, J. Diversity of susceptible hosts in canine distemper virus infection:A systematic review and data synthesis. BMC Vet. Res. 2016, 12, 78. [CrossRef] [PubMed]
6. Pillet, S.; Svitek, N.; von Messling, V. Ferrets as a model for morbillivirus pathogenesis, complications, and vaccines. Curr. Top Microbiol. Immunol. 2009, 330, 73-87. [PubMed]
7. Barrett, T. Morbillivirus infections, with special emphasis on morbilliviruses of carnivores. Vet. Microbiol. 1999, 69, 3-13. [CrossRef]
8. Furuse, Y.; Suzuki, A.; Oshitani, H. Origin of measles virus: Divergence from rinderpest virus between the 11th and 12th centuries. Virol. J. 2010, 7, 52. [CrossRef] [PubMed]
9. Griffin, D.E. Measles virus. In Fields Virology; Knipe, D.M., Howley, P.M., Eds.; LippincottWilliams &Wilkins:Philadelphia, PA, USA, 2013; pp. 1042-1069.
10. Whelan, S.P.; Barr, J.N.;Wertz, G.W. Transcription and replication of nonsegmented negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 2004, 283, 61-119. [PubMed]
11. Von Messling, V.; Oezguen, N.; Zheng, Q.; Vongpunsawad, S.; Braun, W.; Cattaneo, R. Nearby clusters of hemagglutinin residues sustain SLAM-dependent canine distemper virus entry in peripheral blood mononuclear cells. J. Virol. 2005, 79, 5857-5862. [CrossRef] [PubMed]
12. Ader, N.; Brindley, M.A.; Avila, M.; Origgi, F.C.; Langedijk, J.P.; Örvell, C.; Vandevelde, M.; Zurbriggen, A.; Plemper, R.K.; Plattet, P. Structural rearrangements of the central region of the morbillivirus attachment protein stalk domain trigger F protein refolding for membrane fusion. J. Biol. Chem. 2012, 287, 16324-16334. [CrossRef] [PubMed]
13. Ader-Ebert, N.; Khosravi, M.; Herren, M.; Avila, M.; Alves, L.; Bringolf, F.; Örvell, C.; Langedijk, J.P.; Zurbriggen, A.; Plemper, R.K.; et al. Sequential conformational changes in the morbillivirus attachment protein initiate the membrane fusion process. PLoS Pathog. 2015, 11, e1004880. [CrossRef] [PubMed]
14. Lee, J.K.; Prussia, A.; Paal, T.; White, L.K.; Snyder, J.P.; Plemper, R.K. Functional interaction between paramyxovirus fusion and attachment proteins. J. Biol. Chem. 2008, 283, 16561-16572. [CrossRef] [PubMed]
15. Lemon, K.; de Vries, R.D.; Mesman, A.W.; McQuaid, S.; van Amerongen, G.; Yüksel, S.; Ludlow, M.; Rennick, L.J.; Kuiken, T.; Rima, B.K.; et al. Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog. 2011, 7, e1001263. [CrossRef] [PubMed]
16. Von Messling, V.; Milosevic, D.; Cattaneo, R. Tropism illuminated: Lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc. Natl. Acad. Sci. USA 2004, 101, 14216-14221. [CrossRef] [PubMed]
17. Tatsuo, H.; Ono, N.; Yanagi, Y. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J. Virol. 2001, 75, 5842-5850. [CrossRef] [PubMed]
18. Romanets-Korbut, O.; Kovalevska, L.M.; Seya, T.; Sidorenko, S.P.; Horvat, B. Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response. Cell Mol. Immunol. 2015. [CrossRef] [PubMed]
19. Hashiguchi, T.; Ose, T.; Kubota, M.; Maita, N.; Kamishikiryo, J.; Maenaka, K.; Yanagi, Y. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat. Struct. Mol. Biol. 2011, 18, 135-141. [CrossRef] [PubMed]
20. Ono, N.; Tatsuo, H.; Tanaka, K.; Minagawa, H.; Yanagi, Y. V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J. Virol. 2001, 75, 1594-1600. [CrossRef] [PubMed]
21. Vongpunsawad, S.; Oezgun, N.; Braun, W.; Cattaneo, R. Selectively receptor-blind measles viruses:Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J. Virol. 2004, 78, 302-313. [CrossRef] [PubMed]
22. Von Messling, V.; Svitek, N.; Cattaneo, R. Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus. J. Virol. 2006, 80, 6084-6092. [CrossRef] [PubMed]
23. Leonard, V.H.; Hodge, G.; Reyes-Del Valle, J.; McChesney, M.B.; Cattaneo, R. Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys. J. Virol. 2010, 84, 3413-3420. [CrossRef] [PubMed]
24. Pillet, S.; von Messling, V. Canine distemper virus selectively inhibits apoptosis progression in infected immune cells. J. Virol. 2009, 83, 6279-6287. [CrossRef] [PubMed]
25. De Vries, R.D.; Lemon, K.; Ludlow, M.; McQuaid, S.; Yüksel, S.; van Amerongen, G.; Rennick, L.J.; Rima, B.K.; Osterhaus, A.D.; de Swart, R.L.; et al. In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques. J. Virol. 2010, 84, 4714-4724. [CrossRef] [PubMed]
26. Rudd, P.A.; Cattaneo, R.; von Messling, V. Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion. J. Virol. 2006, 80, 9361-9370. [CrossRef] [PubMed]
27. Mühlebach, M.D.; Mateo, M.; Sinn, P.L.; Prüfer, S.; Uhlig, K.M.; Leonard, V.H.; Navaratnarajah, C.K.; Frenzke, M.; Wong, X.X.; Sawatsky, B.; et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011, 480, 530-533. [CrossRef] [PubMed]
28. Noyce, R.S.; Bondre, D.G.; Ha, M.N.; Lin, L.T.; Sisson, G.; Tsao, M.S.; Richardson, C.D. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog. 2011, 7, e1002240. [CrossRef] [PubMed]
29. Pratakpiriya, W.; Seki, F.; Otsuki, N.; Sakai, K.; Fukuhara, H.; Katamoto, H.; Hirai, T.; Maenaka, K.; Techangamsuwan, S.; Lan, N.T.; et al. Nectin4 is an epithelial cell receptor for canine distemper virus and involved in neurovirulence. J. Virol. 2012, 86, 10207-10210. [CrossRef] [PubMed]
30. Birch, J.; Juleff, N.; Heaton, M.P.; Kalbfleisch, T.; Kijas, J.; Bailey, D. Characterization of ovine Nectin-4, a novel peste des petits ruminants virus receptor. J. Virol. 2013, 87, 4756-4761. [CrossRef] [PubMed]
31. Sawatsky, B.; Wong, X.X.; Hinkelmann, S.; Cattaneo, R.; von Messling, V. Canine distemper virus epithelial cell infection is required for clinical disease but not for immunosuppression. J. Virol. 2012, 86, 3658-3666. [CrossRef] [PubMed]
32. Leonard, V.H.; Sinn, P.L.; Hodge, G.; Miest, T.; Devaux, P.; Oezguen, N.; Braun, W.; McCray, P.B.; McChesney, M.B.; Cattaneo, R. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J. Clin. Investig. 2008, 118, 2448-2458. [CrossRef] [PubMed]
33. Moss,W.J.; Ota, M.O.; Griffin, D.E. Measles: Immune suppression and immune responses. Int. J. Biochem. Cell Biol. 2004, 36, 1380-1385. [CrossRef] [PubMed]
34. Von Messling, V.; Springfeld, C.; Devaux, P.; Cattaneo, R. A ferret model of canine distemper virus virulence and immunosuppression. J. Virol. 2003, 77, 12579-12591. [CrossRef] [PubMed]
35. Schobesberger,M.; Summerfield, A.; Doherr, M.G.; Zurbriggen, A.; Griot, C. Canine distemper virus-induced depletion of uninfected lymphocytes is associated with apoptosis. Vet. Immunol. Immunopathol. 2005, 104, 33-44. [CrossRef] [PubMed]
36. De Vries, R.D.; McQuaid, S.; van Amerongen, G.; Yüksel, S.; Verburgh, R.J.; Osterhaus, A.D.; Duprex,W.P.; de Swart, R.L. Measles immune suppression: Lessons from the macaque model. PLoS Pathog. 2012, 8, e1002885. [CrossRef] [PubMed]
37. Schneider-Schaulies, S.; Schneider-Schaulies, J. Measles virus-induced immunosuppression. Curr. Top. Microbiol. Immunol. 2009, 330, 243-269. [PubMed]
38. Zilliox, M.J.; Moss, W.J.; Griffin, D.E. Gene expression changes in peripheral blood mononuclear cells during measles virus infection. Clin. Vaccine Immunol. 2007, 14, 918-923. [CrossRef] [PubMed]
39. Yu, X.L.; Cheng, Y.M.; Shi, B.S.; Qian, F.X.; Wang, F.B.; Liu, X.N.; Yang, H.Y.; Xu, Q.N.; Qi, T.K.; Zha, L.J.; et al. Measles virus infection in adults induces production of IL-10 and is associated with increased CD4+ CD25+ regulatory T cells. J. Immunol. 2008, 181, 7356-7366. [CrossRef] [PubMed]
40. Svitek, N.; von Messling, V. Early cytokine mRNA expression profiles predict Morbillivirus disease outcome in ferrets. Virology 2007, 362, 404-410. [CrossRef] [PubMed]
41. Horvath, C.M.Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur. J. Biochem. 2004, 271, 4621-4628. [CrossRef] [PubMed]
42. Motz, C.; Schuhmann, K.M.; Kirchhofer, A.; Moldt, M.; Witte, G.; Conzelmann, K.K.; Hopfner, K.P. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science 2013, 339, 690-693. [CrossRef] [PubMed]
43. Svitek, N.; Gerhauser, I.; Goncalves, C.; Grabski, E.; Döring, M.; Kalinke, U.; Anderson, D.E.; Cattaneo, R.; von Messling, V. Morbillivirus control of the interferon response: Relevance of STAT2 and mda5 but not STAT1 for canine distemper virus virulence in ferrets. J. Virol. 2014, 88, 2941-2950. [CrossRef] [PubMed]
44. Devaux, P.; Hudacek, A.W.; Hodge, G.; Reyes-Del Valle, J.; McChesney, M.B.; Cattaneo, R. A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys. J. Virol. 2011, 85, 348-356. [CrossRef] [PubMed]
45. Devaux, P.; Hodge, G.; McChesney, M.B.; Cattaneo, R. Attenuation of V- or C-defective measles viruses:Infection control by the inflammatory and interferon responses of rhesus monkeys. J. Virol. 2008, 82, 5359-5367. [CrossRef] [PubMed]
46. Reuter, D.; Schneider-Schaulies, J. Measles virus infection of the CNS: Human disease, animal models, and approaches to therapy. Med. Microbiol. Immunol. 2010, 199, 261-271. [CrossRef] [PubMed]
47. Rima, B.K.; Baczko, K.; Imagawa, D.T.; ter Meulen, V. Humoral immune response in dogs with old dog encephalitis and chromic distemper meningo-encephalitis. J. Gen. Virol. 1987, 68, 1723-1735. [CrossRef] [PubMed]
48. Summers, B.A.; Greisen, H.A.; Appel, M.J. Canine distemper encephalomyelitis: Variation with virus strain. J. Comp. Pathol. 1984, 94, 65-75. [CrossRef]
49. Rudd, P.A.; Bastien-Hamel, L.E.; von Messling, V. Acute canine distemper encephalitis is associated with rapid neuronal loss and local immune activation. J. Gen. Virol. 2010, 91, 980-989. [CrossRef] [PubMed]
50. Esolen, L.M.; Takahashi, K.; Johnson, R.T.; Vaisberg, A.; Moench, T.R.;Wesselingh, S.L.; Griffin, D.E. Brain endothelial cell infection in children with acute fatal measles. J. Clin. Investig. 1995, 96, 2478-2481. [CrossRef] [PubMed]
51. Higgins, R.J.; Krakowka, S.G.; Metzler, A.E.; Koestner, A. Primary demyelination in experimental canine distemper virus induced encephalomyelitis in gnotobiotic dogs. Sequential immunologic and morphologic findings. Acta Neuropathol. 1982, 58, 1-8. [CrossRef] [PubMed]
52. Vandevelde, M.; Zurbriggen, A. Demyelination in canine distemper virus infection: A review. Acta Neuropathol. 2005, 109, 56-68. [CrossRef] [PubMed]
53. Ulrich, R.; Puff, C.; Wewetzer, K.; Kalkuhl, A.; Deschl, U.; Baumgärtner, W. Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination. PLoS ONE 2014, 9, e95917. [CrossRef] [PubMed]
54. Wünschmann, A.; Alldinger, S.; Kremmer, E.; Baumgärtner, W. Identification of CD4+ and CD8+ T cell subsets and B cells in the brain of dogs with spontaneous acute, subacute-, and chronic-demyelinating distemper encephalitis. Vet. Immunol. Immunopathol. 1999, 67, 101-116. [CrossRef]
55. Tipold, A.; Vandevelde, M.;Wittek, R.; Moore, P.; Summerfield, A.; Zurbriggen, A. Partial protection and intrathecal invasion of CD8(+) T cells in acute canine distemper virus infection. Vet. Microbiol. 2001, 83, 189-203. [CrossRef]
56. Seehusen, F.; Baumgärtner,W. Axonal pathology and loss precede demyelination and accompany chronic lesions in a spontaneously occurring animal model of multiple sclerosis. Brain Pathol. 2010, 20, 551-559. [CrossRef] [PubMed]
57. Freeman, A.F.; Jacobsohn, D.A.; Shulman, S.T.; Bellini, W.J.; Jaggi, P.; de Leon, G.; Keating, G.F.; Kim, F.; Pachman, L.M.; Kletzel, M.; et al. A new complication of stem cell transplantation: Measles inclusion body encephalitis. Pediatrics 2004, 114, e657-e660. [CrossRef] [PubMed]
58. Hardie, D.R.; Albertyn, C.; Heckmann, J.M.; Smuts, H.E. Molecular characterisation of virus in the brains of patients with measles inclusion body encephalitis (MIBE). Virol. J. 2013, 10, 283. [CrossRef] [PubMed]
59. Ludlow, M.; Nguyen, D.T.; Silin, D.; Lyubomska, O.; de Vries, R.D.; von Messling, V.; McQuaid, S.; De Swart, R.L.; Duprex, W.P. Recombinant canine distemper virus strain Snyder Hill expressing green or red fluorescent proteins causes meningoencephalitis in the ferret. J. Virol. 2012, 86, 7508-7519. [CrossRef] [PubMed]
60. Bonami, F.; Rudd, P.A.; von Messling, V. Disease duration determines canine distemper virus neurovirulence. J. Virol. 2007, 81, 12066-12070. [CrossRef] [PubMed]
61. Schönberger, K.; Ludwig, M.S.; Wildner, M.; Weissbrich, B. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: A risk estimation. PLoS ONE 2013, 8, e68909. [CrossRef] [PubMed]
62. Okuno, Y.; Nakao, T.; Ishida, N.; Konno, T.; Mizutani, H.; Fukuyama, Y.; Sato, T.; Isomura, S.; Ueda, S.; Kitamura, I. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan. Int. J. Epidemiol. 1989, 18, 684-689. [CrossRef] [PubMed]
63. Cattaneo, R.; Schmid, A.; Eschle, D.; Baczko, K.; ter Meulen, V.; Billeter, M.A. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 1988, 55, 255-265. [CrossRef]
64. Billeter, M.A.; Cattaneo, R.; Spielhofer, P.; Kaelin, K.; Huber, M.; Schmid, A.; Baczko, K.; ter Meulen, V. Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann. NY Acad. Sci. 1994, 724, 367-377. [CrossRef] [PubMed]
65. Thormar, H.; Mehta, P.D.; Brown, H.R. Comparison of wild-type and subacute sclerosing panencephalitis strains of measles virus. Neurovirulence in ferrets and biological properties in cell cultures. J. Exp. Med. 1978, 148, 674-691. [CrossRef] [PubMed]
66. Thormar, H.; Mehta, P.D.; Barshatzky, M.R.; Brown, H.R. Measles virus encephalitis in ferrets as a model for subacute sclerosing panencephalitis. Lab. Anim. Sci. 1985, 35, 229-232. [PubMed]
67. Zinke, M.; Kendl, S.; Singethan, K.; Fehrholz, M.; Reuter, D.; Rennick, L.; Herold, M.J.; Schneider-Schaulies, J. Clearance of measles virus from persistently infected cells by short hairpin RNA. J. Virol. 2009, 83, 9423-9431. [CrossRef] [PubMed]
68. Alves, L.; Khosravi, M.; Avila, M.; Ader-Ebert, N.; Bringolf, F.; Zurbriggen, A.; Vandevelde, M.; Plattet, P. SLAM- and nectin-4-independent noncytolytic spread of canine distemper virus in astrocytes. J. Virol. 2015, 89, 5724-5733. [CrossRef] [PubMed]
69. Watanabe, S.; Ohno, S.; Shirogane, Y.; Suzuki, S.O.; Koga, R.; Yanagi, Y. Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology. J. Virol. 2015, 89, 2710-2717. [CrossRef] [PubMed]
70. Holzmann, H.; Hengel, H.; Tenbusch, M.; Doerr, H.W. Eradication of measles: Remaining challenges. Med. Microbiol. Immunol. 2016, 205, 201-208. [CrossRef] [PubMed]
71. Croghan, D.L. Attenuated live-virus canine distemper vaccines. J. Am. Vet. Med. Assoc. 1966, 149, 662-665. [PubMed]
72. Fulton, B.O.; Sachs, D.; Beaty, S.M.;Won, S.T.; Lee, B.; Palese, P.; Heaton, N.S. Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins. Cell Rep. 2015, 11, 1331-1338. [CrossRef] [PubMed]
73. Zuniga, A.;Wang, Z.; Liniger, M.; Hangartner, L.; Caballero, M.; Pavlovic, J.;Wild, P.; Viret, J.F.; Glueck, R.; Billeter, M.A.; et al. Attenuated measles virus as a vaccine vector. Vaccine 2007, 25, 2974-2983. [CrossRef] [PubMed]
74. Ramsauer, K.; Schwameis, M.; Firbas, C.; Müllner, M.; Putnak, R.J.; Thomas, S.J.; Desprès, P.; Tauber, E.; Jilma, B.; Tangy, F. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: A randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet Infect. Dis. 2015, 15, 519-527. [CrossRef]
75. Miura, R.; Kooriyama, T.; Yoneda, M.; Takenaka, A.; Doki, M.; Goto, Y.; Sanjoba, C.; Endo, Y.; Fujiyuki, T.; Sugai, A.; et al. Efficacy of recombinant canine distemper virus expressing Leishmania antigen against Leishmania challenge in dogs. PLoS Negl. Trop. Dis. 2015, 9, e0003914. [CrossRef] [PubMed]
76. Carpenter, J.W.; Appel, M.J.; Erickson, R.C.; Novilla, M.N. Fatal vaccine-induced canine distemper virus infection in black-footed ferrets. J. Am. Vet. Med. Assoc. 1976, 169, 961-964. [PubMed]
77. Durchfeld, B.; Baumgärtner,W.; Herbst,W.; Brahm, R. Vaccine-associated canine distemper infection in a litter of African hunting dogs (Lycaon pictus). Zentralbl. Vet. B 1990, 37, 203-212. [CrossRef]
78. Nielsen, L.; Søgaard, M.; Karlskov-Mortensen, P.; Jensen, T.H.; Jensen, T.D.; Aasted, B.; Blixenkrone-Møller, M. Humoral and cell-mediated immune responses in DNA immunized mink challenged with wild-type canine distemper virus. Vaccine 2009, 27, 4791-4797. [CrossRef] [PubMed]
79. Stephensen, C.B.;Welter, J.; Thaker, S.R.; Taylor, J.; Tartaglia, J.; Paoletti, E. Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection. J. Virol. 1997, 71, 1506-1513. [PubMed]
80. Fischer, L.; Tronel, J.P.; Pardo-David, C.; Tanner, P.; Colombet, G.; Minke, J.; Audonnet, J.C. Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge. Vaccine 2002, 20, 3485-3497. [CrossRef]
81. Rouxel, R.N.; Svitek, N.; von Messling, V. A chimeric measles virus with canine distemper envelope protects ferrets from lethal distemper challenge. Vaccine 2009, 27, 4961-4966. [CrossRef] [PubMed]
82. Silin, D.; Lyubomska, O.; Ludlow, M.; Duprex, W.P.; Rima, B.K. Development of a challenge-protective vaccine concept by modification of the viral RNA-dependent RNA polymerase of canine distemper virus. J. Virol. 2007, 81, 13649-13658. [CrossRef] [PubMed]
83. Bronson, E.; Deem, S.L.; Sanchez, C.; Murray, S. Serologic response to a canarypox-vectored canine distemper virus vaccine in the giant panda (Ailuropoda melanoleuca). J. Zoo Wildl. Med. 2007, 38, 363-366. [CrossRef]
84. Coke, R.L.; Backues, K.A.; Hoover, J.P.; Saliki, J.T.; Ritchey, J.W.; West, G.D. Serologic responses after vaccination of fennec foxes (Vulpes zerda) and meerkats (Suricata suricatta) with a live, canarypox-vectored canine distemper virus vaccine. J. Zoo Wildl. Med. 2005, 36, 326-330. [CrossRef] [PubMed]
85. Jensen, T.H.; Nielsen, L.; Aasted, B.; Blixenkrone-Møller, M. Early life DNA vaccination with the H gene of Canine distemper virus induces robust protection against distemper. Vaccine 2009, 27, 5178-5183. [CrossRef] [PubMed]
86. Ge, J.;Wang, X.; Tian, M.; Gao, Y.;Wen, Z.; Yu, G.; Zhou,W.; Zu, S.; Bu, Z. Recombinant Newcastle disease viral vector expressing hemagglutinin or fusion of canine distemper virus is safe and immunogenic in minks. Vaccine 2015, 33, 2457-2462. [CrossRef] [PubMed]
87. Wang, F.X.; Zhang, S.Q.; Zhu, H.W.; Yang, Y.; Sun, N.; Tan, B.; Li, Z.G.; Cheng, S.P.; Fu, Z.F.; Wen, Y.J. Recombinant rabies virus expressing the H protein of canine distemper virus protects dogs from the lethal distemper challenge. Vet. Microbiol. 2014, 174, 362-371. [CrossRef] [PubMed]
88. Welter, J.; Taylor, J.; Tartaglia, J.; Paoletti, E.; Stephensen, C.B. Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines. J. Virol. 2000, 74, 6358-6367. [CrossRef] [PubMed]
89. Jensen, T.H.; Nielsen, L.; Aasted, B.; Pertoldi, C.; Blixenkrone-Møller, M. Canine distemper virus DNA vaccination of mink can overcome interference by maternal antibodies. Vaccine 2015, 33, 1375-1381. [CrossRef] [PubMed]
90. Krumm, S.A.; Yan, D.; Hovingh, E.S.; Evers, T.J.; Enkirch, T.; Reddy, G.P.; Sun, A.; Saindane, M.T.; Arrendale, R.F.; Painter, G.; et al. An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model. Sci. Transl. Med. 2014, 6, 232ra52. [CrossRef] [PubMed]
91. Welsch, J.C.; Talekar, A.; Mathieu, C.; Pessi, A.; Moscona, A.; Horvat, B.; Porotto, M. Fatal measles virus infection prevented by brain-penetrant fusion inhibitors. J. Virol. 2013, 87, 13785-13794. [CrossRef] [PubMed]
92. Plemper, R.K.; Doyle, J.; Sun, A.; Prussia, A.; Cheng, L.T.; Rota, P.A.; Liotta, D.C.; Snyder, J.P.; Compans, R.W. Design of a small-molecule entry inhibitor with activity against primary measles virus strains. Antimicrob. Agents Chemother. 2005, 49, 3755-3761. [CrossRef] [PubMed]
93. Moore, T.W.; Sana, K.; Yan, D.; Krumm, S.A.; Thepchatri, P.; Snyder, J.P.; Marengo, J.; Arrendale, R.F.; Prussia, A.J.; Natchus, M.G.; et al. Synthesis and Metabolic Studies of Host Directed Inhibitors for Anti Viral Therapy. ACS Med. Chem. Lett. 2013, 4, 762-767. [CrossRef] [PubMed]
94. Young, M.K.; Nimmo, G.R.; Cripps, A.W.; Jones, M.A. Post-exposure passive immunisation for preventing measles. Cochrane Database Syst. Rev. 2014, CD010056. [CrossRef]
95. Hirayama, N.; Senda, M.; Nakashima, N.; Takagi, M.; Sugiyama, M.; Yoshikawa, Y.; Yamanouchi, K. Protective effects of monoclonal antibodies against lethal canine distemper virus infection in mice. J. Gen. Virol. 1991, 72, 2827-2830. [CrossRef] [PubMed]